Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antiviral activity against VZV infected in human thyroid gland assessed as inhibition of virus induced cytopathic effect incubated for 11 days by crystal violet staining assay
Assay data:1 Tested
SummaryPubMed Citation
Antiviral activity against VZV
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antiviral activity against VZV strain Oka bearing wild type thymidine kinase assessed as reduction in virus induced cytopathogenicity
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
Antiviral activity against VZV Ellen infected in HFF cells assessed as reduction in viral replication measured after 14 days
Assay data:1 Active, 7 Tested
SummaryCompounds, ActivePubMed Citation
Antiviral activity against VZV TK- infected in HEL cells assessed as reduction in virus plaque formation
Antiviral activity against VZV TK+ infected in HEL cells assessed as reduction in virus plaque formation
Assay data:3 Active, 1 Activity ≤ 1 µM, 7 Tested
Antiviral activity against thymidine kinase deficient Varicella zoster-virus O7-1 strain infected in HEL cells assessed as reduction in plaque formation by microscopic analysis
Assay data:1 Active, 6 Tested
Antiviral activity against Varicella zoster-virus OKA strain harboring thymidine kinase infected in HEL cells assessed as reduction in plaque formation by microscopic analysis
Assay data:2 Active, 2 Activity ≤ 1 µM, 6 Tested
Antiviral activity against Varicella Zoster virus infected in HFF cells
Assay data:3 Tested
In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts
Assay data:2 Tested
In vitro antiviral activity against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts.
In vitro antiviral activity tested against herpesvirus, VZV, OKA strain by plaque reduction assay in human foreskin fibroblasts.
In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts
In vitro antiviral activity against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts.
In vitro antiviral activity tested against herpesvirus, VZV, Ellen strain by plaque reduction assay in human foreskin fibroblasts.
compound was tested for antiherpes activity against VZV(Ellen) in tissue culture by plaque reduction assay
Assay data:5 Active, 2 Activity ≤ 1 µM, 7 Tested
Compound was evaluated for the antiviral activity against Varicella-Zoster virus (VZV) Oka strain by using plaque reduction assay.
Assay data:5 Tested
Antiviral activity against Varicella zoster virus (ppIIa strain)
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on